{
}
The Swiss stock market closed lower, impacted by US tariffs on cars and parts, with the SMI falling 0.7% to 12,867 points. UBS shares plummeted 4.1% after a downgrade by Bank of America, while Roche and other companies also faced losses. In contrast, Nestlé and Alcon saw gains due to positive developments in their business sectors.
The Swiss stock market closed lower, impacted by US tariffs on cars and parts, with the SMI falling 0.7% to 12,867 points. UBS shares plummeted 4.1% after a downgrade by Bank of America, while Roche and other companies also faced losses. In contrast, Nestlé and Alcon saw positive movements due to business developments.
With low interest rates likely to persist, the stock market is poised for growth as companies can borrow cheaply to invest. However, geopolitical tensions and uncertainties may lead to volatility in 2025, making high-dividend stocks a safer investment choice for stable returns. The Swiss equity market, known for its defensive nature, features companies like Nestlé and Roche that offer attractive dividends, providing a buffer against market fluctuations.
Swiss pharmaceutical giants Roche and Novartis have abandoned their diversity, equity, and inclusion (DEI) targets in the USA, following new political guidelines from the Trump administration that label such measures as "illegal and wasteful." Roche has informed its global workforce that DEI targets will no longer be publicly communicated, while UBS has removed DEI references from its reports. Other Swiss firms like ABB and Nestlé are currently maintaining a low profile but may adjust their policies based on local conditions.
Luca Santarelli, a successful biotech entrepreneur from Italy, has founded and sold three start-ups in Basel, amassing billions. After a decade at Roche, he transitioned to entrepreneurship, driven by a desire to apply research in innovative ways. His latest venture, Windward Bio, has attracted significant investor funding, reflecting his impactful career in the biotech sector.
Amadeus Fire's cautious outlook impacted cyclically sensitive stocks, with Givaudan, Sika, and Holcim among the notable decliners. The US stock market saw declines, particularly in Nike and FedEx, amid economic concerns and a major futures expiry day. Oil prices remained stable, with Brent slightly down and WTI up, as geopolitical tensions continue to influence the market.
Roche and UBS, two major Swiss corporations, are abandoning their diversity targets in response to a decree from US President Donald Trump that prohibits workplace equality initiatives. Roche will no longer pursue quotas for women in management or ethnic minorities, shifting its focus to "inclusion and belonging." Similarly, UBS has removed all references to "Diversity, Equity and Inclusion" from its 2024 annual report, erasing previously set DE&I goals.
Morgan Stanley has upgraded Zealand Pharma to Overweight, citing the long-term potential of its obesity treatment, petrelintide, following a partnership with Roche. Despite current market challenges, analysts believe the obesity market opportunity remains robust, with petrelintide positioned as a leading therapeutic. The recent decline in Zealand's stock price is seen as an attractive entry point for investors, with potential upside from upcoming data and the partnership's implications for future sales.
The Swiss stock market remained positive following the Swiss National Bank's decision to cut its key interest rate by 25 basis points to 0.25%. Analysts expect this to be the last cut for the year, with inflation forecasts suggesting no need for further reductions. The SMI index rose by 0.11%, led by Nestlé, while Swissquote shares fell by 7.7% despite reporting a strong fiscal performance.
The Swiss stock market remained positive as the Swiss National Bank (SNB) cut its key interest rate by 25 basis points to 0.25%, a move anticipated by analysts. The SMI index rose by 0.11%, led by Nestlé and Alcon, while Swissquote shares fell 7.7% despite reporting a strong fiscal performance. HOCN shares surged 19% amid plans to appeal a delisting decision.
Hoffmann-La Roche AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Swiss stock market declines amid trade tensions and corporate earnings reports
United States Dollar
Idorsia Ltd
Nestle SA
Sika AG
Implenia AG
Adecco Group AG
Hoffmann-La Roche AG
Schindler Holding AG
Alcon Inc.
CHE
Show more
19:21 27.03.2025
Swiss stock market declines amid US tariff concerns and weak bank performance
Idorsia Ltd
Nestle SA
Sika AG
Implenia AG
Adecco Group AG
Hoffmann-La Roche AG
Schindler Holding AG
CHE
Show more
17:48 27.03.2025
stable income through high dividend stocks in uncertain markets
United States Dollar
S Tempo Swiss Life AM
Novartis AG
Swiss Re AG
Zurich, Agence générale Christian Meier SA
Hoffmann-La Roche AG
Nestlé S.A.
CHE
Jean Rochefort
Show more
11:10 27.03.2025
Swiss companies abandon diversity targets in the United States
United States Dollar
Novartis AG
Hoffmann-La Roche AG
ABB Ltd
Nestlé S.A.
USA
CHE
Nicole Niedermann
Rebekka Schnell
Show more
11:00 24.03.2025
biotech entrepreneur luca santarelli's journey from doctor to startup success
08:44 24.03.2025
market fluctuations amid cautious outlook and geopolitical tensions
Euro
United States Dollar
Amadeus FiRe AG
Swisscom AG
GAM, Antonio Gheller
Morgan Stanley
Nestlé S.A.
FedEx Corp
NIKE, Inc.
RICHEMONT, Intellectual Property Services
Hoffmann-La Roche AG
Micron Technology, Inc.
DEU
IRN
USA
CHN
CHE
Show more
05:00 24.03.2025
Swiss corporations abandon diversity targets in response to US political climate
11:20 21.03.2025
Morgan Stanley upgrades Zealand Pharma citing long-term obesity market potential
Euro
Danish Krone
United States Dollar
Zealand Pharma A/S
Hoffmann-La Roche AG
Novo Nordisk A/S
DNK
USA
Show more
09:56 21.03.2025
swiss stock market remains positive after snb interest rate cut
Swiss Franc
Novartis AG
Swissquote Group Holding Ltd
Nestlé S.A.
Julius Bär Gruppe AG
Holcim AG
Alcon Inc.
Hoffmann-La Roche AG
Adecco Group AG
RICHEMONT, Intellectual Property Services
The Swatch Group AG
Sonova R
Axon Partners Group, S.A.
Sandoz Group AG
CHE
Arthur Jurus
Karsten Junius
Philipp Merkt
Show more
11:36 20.03.2025
Swiss stock market remains positive after SNB interest rate cut
Swiss Franc
Novartis AG
Swissquote Group Holding Ltd
Nestlé S.A.
Hocn AG
Holcim AG
Alcon Inc.
Hoffmann-La Roche AG
Adecco Group AG
RICHEMONT, Intellectual Property Services
The Swatch Group AG
Sonova R
Axon Partners Group, S.A.
Sandoz Group AG
CHE
Arthur Jurus
Karsten Junius
Philipp Merkt
Show more
11:35 20.03.2025
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Banking Regulations
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
Central Bank Actions
CEO Changes
GDP Growth & Recession Forecasts
Global Trade Developments
Industry Mergers & Acquisitions
Financial Scams and Security
Inflation and Monetary Impact
Market Analysis and Predictions
Government Policies
Government Economic Policies
Supply Chain Management
Domestic Politics
Startups & Entrepreneurship
Countries:
Companies:
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Bank of America Corporation
Barclays PLC
Wells Fargo & Company
Citigroup Inc.
Deutsche Bank Money Market PP
Morgan Stanley
Huawei Technologies CO. Ltd.
Lloyds Banking Group plc
Credit Suisse Strategic Income I
AXA SA
Safran SA
Banco Santander, S.A.
Novartis AG
NVIDIA Corporation
Swiss Re AG
Beazley plc
Currencies:
United States Dollar
Euro
Chinese Yuan
British Pound Sterling
Swiss Franc
Japanese Yen
Indian Rupee
Russian Ruble
Canadian Dollar
Australian Dollar
United Arab Emirates Dirham
Indonesian Rupiah
Saudi Riyal
South Korean Won
Danish Krone
Offshore Chinese Yuan
Hong Kong Dollar
Mexican Peso
Malaysian Ringgit
Vietnamese Đồng
People: